Diphenhydramine half-life
A nine-hour representative value sits near the longer end of reported adult estimates and is retained with age and overdose context visible.
Every curve begins at 100%. No dose or measured body concentration is assumed.
X-axis: elapsed time. Y-axis: modeled percentage of the relative starting point remaining. The shaded band shows the reported half-life range. This is a mathematical visualization, not a personal concentration estimate.
Diphenhydramine: evidence and interpretation notes
What the representative value means
A nine-hour representative value sits near the longer end of reported adult estimates and is retained with age and overdose context visible. Sedation and anticholinergic effects are not inferred from the curve.
The calculator follows Diphenhydramine with a 9-hour half-life. That simplification is useful for curve shape and comparison, but it is not an individualized pharmacokinetic estimate.
Diphenhydramine can differ by age, formulation, anticholinergic sensitivity, and co-medications. The curve should not be used to judge sleep safety, driving safety, or next-day functioning.
What each source contributes
- DailyMed: ALLERGY CHILDRENS (DIPHENHYDRAMINE HCL) SOLUTION [DOLGENCORP, LLC]. This product label adds formulation-specific pharmacokinetic context and does not represent every route or product.
- PubChem: Diphenhydramine. This identity record confirms names and compound identity and does not supply a human half-life.
- Elimination half-life of diphenhydramine in overdose. This supporting literature record adds compound-specific background and is used only within the limits of its design.
For Diphenhydramine, the numerical model is tied most closely to DailyMed: ALLERGY CHILDRENS (DIPHENHYDRAMINE HCL) SOLUTION [DOLGENCORP, LLC]. As a product label, it adds formulation-specific pharmacokinetic context; it does not represent every route or product.
Why the range stays visible
The 4-to-9-hour range is retained beside the 9-hour input for Diphenhydramine. It is not an uncertainty slider or a personalized prediction; it shows that the cited literature does not reduce to one invariant value.
InterpretationReading the curve and its category context
Reading this curve
HalfLifeDB uses 9 h as a representative input for Diphenhydramine. In the simplified model, about 15.7% remains after 24 hours and about 3% remains after five half-lives, or roughly 45 h.
This sits in the same-day range. The chart is useful for seeing the bend of the curve across a day or two, but it should not be treated as a personal clock. The curve is relative: it does not estimate a person's measured concentration, effects, impairment, or time to clearance.
antihistamine context
Antihistamine profiles can show a gap between pharmacokinetic persistence and perceived sedation, alertness, or next-day effects.
- Sedation and anticholinergic effects are not predicted by the curve.
- Age, co-medications, and formulation can change practical interpretation.
- Detection, impairment, and safety questions require context beyond half-life.
ComparisonTimeline checkpoints and nearby profiles
Diphenhydramine timeline checkpoints
| Elapsed time | Modeled remaining | Reading note |
|---|---|---|
| 12 h | 39.7% | Meaningful modeled decline, not near-zero |
| 24 h | 15.7% | Long-tail portion of the model |
| 2.0 days | 2.48% | Low modeled remainder, not a clearance guarantee |
| 3.0 days | 0.39% | Low modeled remainder, not a clearance guarantee |
| 5.0 days | 0.01% | Low modeled remainder, not a clearance guarantee |
Nearby profiles by half-life
These entries sit near Diphenhydramine within the antihistamine group when sorted by representative half-life. That makes them curve comparisons, not statements about equal potency, effects, or risk.
No nearby published profiles are available in this category.
EvidencePharmacokinetic inputs and source trail
Pharmacokinetics at a glance
| Representative half-life | 9 h |
|---|---|
| Reported range | 4 h to 9 h |
| Curve type | Normalized, first-order decline |
Selection note: A nine-hour representative value sits near the longer end of reported adult estimates and is retained with age and overdose context visible. Sedation and anticholinergic effects are not inferred from the curve.
Sources and evidence context
A linked record is not automatically proof of the displayed value. Study, labeling, review, and compound identity sources serve different purposes; notes below identify limitations when they are known.
- Official labeling DailyMed label: ALLERGY CHILDRENS (DIPHENHYDRAMINE HCL) SOLUTION [DOLGENCORP, LLC].Official U.S. product labeling used for formulation and labeled pharmacokinetic context; its statements apply to the described product.
- Identity record PubChem Compound Summary: Diphenhydramine.Compound identity and naming record. It supplies chemistry context, not independent numerical support for the model.
- Research abstract PubMed: Elimination half-life of diphenhydramine in overdose.Supporting literature record. Its role and study design should be read from the linked source before applying any numerical finding.
BoundariesWhat this page cannot answer and where to continue
What this page does not answer
- It does not estimate impairment, intoxication, or fitness to drive.
- It does not predict urine, blood, saliva, or hair test results.
- It does not model repeated exposure, tolerance, withdrawal, or interactions.
- It does not replace clinician, pharmacist, toxicologist, or emergency guidance.
Continue with context
- All substance profiles
- Browse the antihistamine group
- Compare this curve
- Clearance and volume of distribution
- Bioavailability, route, and formulation
- Active metabolites and parent compounds
- First-order vs nonlinear kinetics
- Detection windows vs half-life
- Reading labels and source quality
Read the medical disclaimer, methodology, and research standards before using the model for comparison.